Literature DB >> 3909270

Stimulation of DNA synthesis in human fibroblasts by human pancreatic secretory trypsin inhibitor.

M Ogawa, T Tsushima, Y Ohba, N Ogawa, S Tanaka, M Ishida, T Mori.   

Abstract

Human pancreatic secretory trypsin inhibitor stimulated [3H]thymidine incorporation into DNA in human fibroblasts at concentrations present in human serum. Combined addition of human pancreatic secretory trypsin inhibitor and porcine insulin gave more than additive stimulation of [3H]thymidine incorporation.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3909270

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


  13 in total

1.  Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.

Authors:  Yi-Ting Chen; Shu-Chuan Tsao; Shyng-Shiou F Yuan; Hung-Pei Tsai; Chee-Yin Chai
Journal:  Pathol Oncol Res       Date:  2015-06-03       Impact factor: 3.201

2.  Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development.

Authors:  Ulf-Håkan Stenman
Journal:  Asian J Androl       Date:  2011-05-23       Impact factor: 3.285

3.  Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice.

Authors:  T C Freeman; R J Playford; C Quinn; K Beardshall; L Poulter; J Young; J Calam
Journal:  Gut       Date:  1990-11       Impact factor: 23.059

4.  Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development.

Authors:  Jun Wang; Masaki Ohmuraya; Masahiko Hirota; Hideo Baba; Gang Zhao; Motohiro Takeya; Kimi Araki; Ken-ichi Yamamura
Journal:  Histochem Cell Biol       Date:  2008-04-02       Impact factor: 4.304

5.  Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; K Uda; T Mori
Journal:  Int J Pancreatol       Date:  1994-02

6.  Pancreatic secretory trypsin inhibitor in human Brunner's glands.

Authors:  H Bohe; M Bohe; C Lindström; K Ohlsson
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

7.  Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol.

Authors:  R J Playford; J J Batten; T C Freeman; K Beardshall; D A Vesey; G C Fenn; J H Baron; J Calam
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Influence of inflammatory bowel disease on the distribution and concentration of pancreatic secretory trypsin inhibitor within the colon.

Authors:  R J Playford; A M Hanby; K Patel; J Calam
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 9.  Hereditary pancreatitis: dilemmas in differential diagnosis and therapeutic approach.

Authors:  Aikaterini Mastoraki; Adelais Tzortzopoulou; Smaragda Tsela; Nikolaos Danias; George Sakorafas; Vasilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  J Gastrointest Cancer       Date:  2014-03

10.  The role of SPINK1 in ETS rearrangement-negative prostate cancers.

Authors:  Scott A Tomlins; Daniel R Rhodes; Jianjun Yu; Sooryanarayana Varambally; Rohit Mehra; Sven Perner; Francesca Demichelis; Beth E Helgeson; Bharathi Laxman; David S Morris; Qi Cao; Xuhong Cao; Ove Andrén; Katja Fall; Laura Johnson; John T Wei; Rajal B Shah; Hikmat Al-Ahmadie; James A Eastham; Scott E Eggener; Samson W Fine; Kristina Hotakainen; Ulf-Håkan Stenman; Alex Tsodikov; William L Gerald; Hans Lilja; Victor E Reuter; Phillip W Kantoff; Peter T Scardino; Mark A Rubin; Anders S Bjartell; Arul M Chinnaiyan
Journal:  Cancer Cell       Date:  2008-06       Impact factor: 31.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.